Jaguar Health (JAGX) Other Working Capital Changes (2014 - 2026)
Jaguar Health (JAGX) reported Other Working Capital Changes of -$49000.0 for Q1 2026, down 110.06% year-over-year from $487000.0 in Q1 2025, and up 95.67% quarter-over-quarter from -$1.1 million in Q4 2025.
Jaguar Health (JAGX) Other Working Capital Changes (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Other Working Capital Changes data on file, last reported at -$49000.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$49000.0, down 110.06% year-over-year; the trailing twelve-month figure through Mar 2026 was -$808000.0 (down 665.03% YoY), and the FY2025 annual result was -$272000.0, up 39.69% from the prior year.
- Other Working Capital Changes rose to -$49000.0 in Q1 2026 per JAGX's latest filing, from -$1.1 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $5.3 million in Q4 2023 and troughed at -$4.1 million in Q3 2023.
- A 5-year average of $281705.9 and a median of -$49000.0 in 2026 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 1483.64% in 2022 and fell as far as 8341.18% in 2022.
- A 5-year view of Other Working Capital Changes shows it stood at $761000.0 in 2022, then jumped by 597.9% to $5.3 million in 2023, then slumped by 122.9% to -$1.2 million in 2024, then gained by 6.99% to -$1.1 million in 2025, then surged by 95.67% to -$49000.0 in 2026.
- Business Quant data shows JAGX's Other Working Capital Changes at -$49000.0 in Q1 2026, -$1.1 million in Q4 2025, and $996000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49,000.00 |
| Mar 31, 2026 | -49,000.00 |
| Dec 31, 2025 | -1.13 Mn |
| Dec 31, 2025 | -1.13 Mn |
| Sep 30, 2025 | 996,000.00 |
| Sep 30, 2025 | 996,000.00 |
| Jun 30, 2025 | -624,000.00 |
| Jun 30, 2025 | -624,000.00 |
| Mar 31, 2025 | 487,000.00 |
| Mar 31, 2025 | 487,000.00 |
| Dec 31, 2024 | -1.22 Mn |
| Dec 31, 2024 | -1.22 Mn |
| Sep 30, 2024 | -1.90 Mn |
| Sep 30, 2024 | -1.90 Mn |
| Jun 30, 2024 | 2.77 Mn |
| Jun 30, 2024 | 2.77 Mn |
| Mar 31, 2024 | -107,000.00 |
| Mar 31, 2024 | -107,000.00 |
| Dec 31, 2023 | 5.31 Mn |
| Dec 31, 2023 | 5.31 Mn |